-
Post date
August 10, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Eaton, Health Science, Mushrooms, psilocybin, Psychedelics, revive, Revive Therapeutics, RVV.C, Scribes, Strokes, TBI, UHSA, University of Wisconsin
-
Post date
August 10, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Eaton, Health Science, Mushrooms, psilocybin, Psychedelics, revive, Revive Therapeutics, RVV.C, Strokes, TBI, UHSA, University of Wisconsin
-
Post date
July 4, 2021
-
Posted by
Lukas Kane
-
Posted in
Biotech, Breakthrough Therapy, Bucillamine, CBD research and development, clinical testing, Fast Track, FDA approval, Featured Content, Health Science, ischemia-reperfusion injury, Kane, Mushroom Moves, Mushrooms, Orphan Drug, preclinical testing, preclinical trials, psilcoybin, Psychedelics, Rare Pediatric Disease, research and development, Revive Therapeutics, RVV.C, Scribes, Series, UCSF, University of California
-
Post date
June 17, 2021
-
Posted by
Piers Eaton
-
Posted in
Antigua and Barbuda, Eaton, Health Science, Mushrooms, Oral thin fim, OTF, psilocybin, Psychedelics, research, revive, Revive Therapeutics, RVV, RVV.C, Scribes, UHSA
-
Post date
June 15, 2021
-
Posted by
Taylor Gavinchuk
-
Posted in
best shroom boom stocks, Canadian shroom-stocks, Health Science, PharmaTher, pharmather revive, pharmather stock, PHRM.C, Psychedelics, psychedelics stocks 2021, RVV.C, shroom companies stocks, top biotech stocks 2021